Skip to main content
Equibles

Squarepoint Ops LLC

Position in MRNA — Moderna, Inc.

CIK 1642575 NEW YORK, NY
Back to MRNA Full portfolio

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,178,674
-$9,626,943 QoQ
Shares Held
16,831
-92.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#280
of 777 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Jun 30, 2026
CallValue
$21,912,387
CallShares
312,900
PutValue
$22,479,630
PutShares
321,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. MRNA ranks #104 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in MRNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,178,674 16,831
2026-06-30 $21,912,387 312,900
2026-06-30 $22,479,630 321,000
2026-03-31 $46,766,480 920,600
2026-03-31 $38,491,160 757,700
2026-03-31 $10,805,617 212,709
2025-12-31 $28,758,500 975,195
2025-12-31 $76,951,206 2,609,400
2025-12-31 $35,727,135 1,211,500
2025-09-30 $65,719,269 2,544,300
2025-09-30 $30,021,382 1,162,268
2025-09-30 $117,283,698 4,540,600
2025-06-30 $84,488,857 3,062,300
2025-06-30 $69,027,421 2,501,900
2025-06-30 $3,001,295 108,782
2025-03-31 $18,974,655 669,300
2025-03-31 $20,588,960 726,242
2025-03-31 $44,458,470 1,568,200
2024-12-31 $48,207,852 1,159,400
2024-12-31 $48,706,812 1,171,400
2024-12-31 $37,125,451 892,868
2024-09-30 $30,975,705 463,500
2024-09-30 $27,480,496 411,200
2024-09-30 $26,841,133 401,633
2024-06-30 $18,272,775 153,876
2024-06-30 $12,908,125 108,700
2024-06-30 $19,201,875 161,700
2024-03-31 $34,354,944 322,400
2024-03-31 $33,257,376 312,100
2024-03-31 $958,613 8,996
2023-12-31 $28,512,315 286,700
2023-12-31 $31,535,595 317,100
2023-12-31 $15,048,376 151,316
2023-09-30 $6,601,986 63,917
2023-09-30 $26,597,175 257,500
2023-09-30 $35,035,968 339,200
2023-06-30 $55,428,300 456,200
2023-06-30 $47,190,600 388,400
2023-06-30 $24,077,290 198,167
2023-03-31 $52,601,150 342,500
2023-03-31 $26,799,710 174,500
2023-03-31 $25,484,604 165,937
2022-12-31 $443,122 2,467
2022-12-31 $36,534,708 203,400
2022-12-31 $12,591,362 70,100
2022-09-30 $13,145,143 111,164
2022-09-30 $12,120,625 102,500
2022-09-30 $36,208,150 306,200
2022-06-30 $41,497,925 290,500
2022-06-30 $8,656,710 60,600

Report a Problem

Category
Description
Email (optional, for follow-up)